Elsevier

Developmental Brain Research

Volume 81, Issue 2, 16 September 1994, Pages 269-283
Developmental Brain Research

Expression of mouse brain soluble guanylyl cyclase and NO synthase during ontogeny

https://doi.org/10.1016/0165-3806(94)90313-1Get rights and content

Abstract

The spatial and temporal distribution of soluble guanylyl cyclase and nitric oxide synthase mRNA was determined during embryonic and postnatal development of the mouse brain. This was achieved by in situ hybridization of specific probes for soluble β1 guanylyl cyclase subunit and nitric oxide synthase mRNA on mouse brain sections at late fetal development (19-day embryo) and different stages of postnatal development (3, 7, 15 days, and adult). In the embryo, soluble guanylyl cyclase transcripts are weakly expressed in the central nervous system. Following birth their expression increases in the striatum and neocortex, and they are widely distributed in the adult brain (layer II and V–VI of the cortex, olfactory bulb, striatum. Purkinje cell layer of the cerebellum). In contrast, nitric oxide synthase mRNA was expressed in several embryonic structures of the brain (different layers of the cortical neuroepithelium, colliculi neuroepithelium, pons), and markedly reduced at early postnatal stage, except in the accessory olfactory bulb and pediculopontine nuclei. Nitric oxide synthase transcripts progressively appear, within two weeks following birth, in the striatum and the cerebral cortex but they were specifically confined to isolated cells. During this period, this mRNA also increased in hippocampus, in discrete nuclei (hypothalamus, pontine) and in the molecular layer of the cerebellum. The situation in the adult was similar to the one observed at 15 days. These results show a general lack of regional colocalization of soluble guanylyl cyclase and NOS mRNA during ontogeny, thus suggesting an independent regulation of the related genes.

Reference (52)

  • MeldrumB. et al.

    Excitatory amino acid neurotoxicity and neurodegenerative disease

    Trends Pharmacol. Sci.

    (1990)
  • MikiN. et al.

    Activation of cerebral guanylyl cyclase by nitric oxide

    Biochem. Biophys. Res. Commun.

    (1977)
  • NakaneM. et al.

    Light and electron microscopic demonstration of guanylyl cyclase in rat brain

    Brain Res.

    (1983)
  • NakaneM. et al.

    Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylyl cyclase from rat lung

    Biochem. Biophys. Res. Commun.

    (1988)
  • ThompsonW.J.

    Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function

    Pharmacol. Ther.

    (1991)
  • VincentS.R. et al.

    Histochemical mapping of nitric oxide synthase in the rat brain

    Neuroscience

    (1992)
  • ArianoM.A. et al.

    Immunohistochemical localization of guanylyl cyclase within neurons of rat brain

    Proc Natl Acad Sci USA

    (1982)
  • BayerS.A.

    Development of the hippocampal region in the rat. II. Morphogenesis during embryonic and early postnatal life

    J. Comp. Neurol.

    (1980)
  • BillingseyM.L. et al.

    Developmental expression of calmodulin-dependent cyclic nucleotide phosphodiesterase in rat brain

    Dev. Brain Res.

    (1990)
  • BlissT.V.P. et al.

    Long lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path

    J. Physiol.

    (1973)
  • BredtD.S. et al.

    Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase

    Nature

    (1991)
  • BredtD.S. et al.

    Localization of nitric oxide synthase indicating a neural role for nitric oxide

    Nature

    (1990)
  • BredtD.S. et al.

    Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum

  • BrüneB. et al.

    Activation of a cytosolic ADP-ribosyltransferase by nitric oxide generating agents

    J. Biol. Chem.

    (1989)
  • BrüneB. et al.

    Activation of soluble guanylyl cyclase by carbon monoxide and inhibition by superoxide anion

    Eur. J. Biochem.

    (1990)
  • Chan-PalayV. et al.

    Immunocytochemical localization of cyclic GMP: light and electron microscope evidence for involvement of neuroglia

  • Cited by (91)

    • Neuronal and brain morphological changes in animal models of schizophrenia

      2016, Behavioural Brain Research
      Citation Excerpt :

      NO plays a key role in synaptogenesis and synaptic plasticity which may produce functional modifications in brain circuits [131,132]. Particularly, high levels of NO are observed in hippocampus, frontal cortex and striatum, after labor and these levels decrease after a couple of weeks post birth [133,134]. Therefore NO may be important in the establishment of neuronal networks in the rat.

    • Nitric oxide neurons and neurotransmission

      2010, Progress in Neurobiology
    • Neonatal administration of N-omega-nitro-l-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by d-amphetamine in postpubertal rats

      2008, Neuropharmacology
      Citation Excerpt :

      NO derived from nNOS contributes to excitotoxicity and free-radical cascades (Beckman, 1994; Dawson et al., 1996; Schulz et al., 1995), iNOS may control stress-induced NO accumulation in the cortex (Madrigal et al., 2003), and eNOS mediates compensatory vasodilatory responses that protect the brain from lack of oxygen due to altered blood flow (Huang et al., 1996; Iadecola et al., 1994). High levels of NOS exist in the hippocampus, frontal cortex and striatum of the rat immediately after labor, decreasing between one and two weeks after birth (de Vente and Steinbusch, 1992; Giuili et al., 1994; Markerink-Van Ittersum et al., 1997; Smigrodzki and Levitt, 1996; van Eden et al., 1996). NO likely plays an important role in the storage, uptake, and release of dopamine (DA) and glutamate, both being implicated in schizophrenia (Boehning and Snyder, 2003; Fricchione and Stefano, 2005; Kiss et al., 2004; Pepicelli et al., 2004; Pogun and Kuhar, 1994; Salum et al., 2006; Wiley et al., 1997).

    • The role of free radicals in cerebral hypoxia and ischemia

      2005, Free Radical Biology and Medicine
    View all citing articles on Scopus
    View full text